Stock
Nasdaq:
DEPO
Price:
2.80 -0.06
Volume:
156,957
In The News
February 2, 2010
Depomed to Present at the 12th Annual BIO CEO & Investor Conference
February 1, 2010
Depomed Announces Allowance of U.S. Patent Covering Gastric Retentive Gabapentin Dosage Forms
January 21, 2010
Depomed Announces Receipt of $500,000 Milestone Payment from Covidien for the Development of a Second Formulation
January 19, 2010
Depomed Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
November 30, 2009
Depomed Files Patent Infringement Lawsuit Against Lupin Limited